MGCND00EP1

· MGC Pharmaceuticals d.o.o

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MGCND00EP1, covering 2024-06-03 to 2024-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant Epilepsies [Phase 2]

See pricing